MAGED1 and neoplasm: Neurotrophin receptor-interacting MAGE homologue (NRAGE) is generally considered to be a tumor suppressor, yet Yang et al. found that NRAGE significantly promoted esophageal carcinoma, mainly via upregulation of PCNA.